Biofrontera Stock Target Price
| BFRI Stock | USD 1.79 0.17 8.67% |
Biofrontera fundamentals help investors to digest information that contributes to Biofrontera's financial success or failures. It also enables traders to predict the movement of Biofrontera Stock. The fundamental analysis module provides a way to measure Biofrontera's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofrontera stock.
Biofrontera | Target Price |
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Biofrontera Fundamentals
| Return On Equity | -1.4 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (0.59) % | ||||
| Operating Margin | (0.36) % | ||||
| Current Valuation | 13.09 M | ||||
| Shares Outstanding | 5.09 M | ||||
| Shares Owned By Insiders | 28.00 % | ||||
| Shares Owned By Institutions | 33.93 % | ||||
| Number Of Shares Shorted | 43.98 K | ||||
| Price To Book | 2.22 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 34.07 M | ||||
| Gross Profit | 13.49 M | ||||
| EBITDA | (20.29 M) | ||||
| Net Income | (20.13 M) | ||||
| Cash And Equivalents | 31.91 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 5.4 M | ||||
| Current Ratio | 3.16 X | ||||
| Book Value Per Share | 3.16 X | ||||
| Cash Flow From Operations | (24.89 M) | ||||
| Short Ratio | 0.29 X | ||||
| Earnings Per Share | (13.02) X | ||||
| Target Price | 16.0 | ||||
| Number Of Employees | 83 | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 9.11 M | ||||
| Total Asset | 27.93 M | ||||
| Retained Earnings | (99.65 M) | ||||
| Working Capital | 4.99 M | ||||
| Net Asset | 27.93 M |
About Biofrontera Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biofrontera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofrontera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofrontera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biofrontera in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biofrontera's short interest history, or implied volatility extrapolated from Biofrontera options trading.
Pair Trading with Biofrontera
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofrontera position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will appreciate offsetting losses from the drop in the long position's value.Moving against Biofrontera Stock
| 0.83 | LGVN | Longeveron LLC Earnings Call This Week | PairCorr |
| 0.79 | IMRX | Immuneering Corp Earnings Call This Week | PairCorr |
| 0.78 | TXG | 10X Genomics | PairCorr |
| 0.76 | IMCR | Immunocore Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
The ability to find closely correlated positions to Biofrontera could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biofrontera when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biofrontera - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biofrontera to buy it.
The correlation of Biofrontera is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biofrontera moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biofrontera moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biofrontera can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biofrontera Piotroski F Score and Biofrontera Altman Z Score analysis. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Biofrontera's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.02) | Revenue Per Share 22.034 | Quarterly Revenue Growth 0.045 | Return On Assets (0.34) | Return On Equity (1.40) |
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.